ImmunityBio, Inc. (IBRX)
9.11
+0.50
(+5.81%)
USD |
NASDAQ |
Feb 20, 14:13
ImmunityBio EPS Diluted (Quarterly) : -0.071 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Novavax, Inc. | -1.246 |
| Rapt Therapeutics, Inc. | -0.652 |
| Moderna, Inc. | -2.107 |
| Corcept Therapeutics, Inc. | 0.1621 |
| Plus Therapeutics, Inc. | -0.0412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -67.27M |
| Revenue (Quarterly) | 32.06M |
| Total Expenses (Quarterly) | 99.31M |
| Enterprise Value | 9.085B |
| Gross Profit Margin (Quarterly) | 87.12% |
| Profit Margin (Quarterly) | -209.8% |
| Earnings Yield | -4.62% |
| Normalized Earnings Yield | -4.940 |